As part of the Governor’s Open for Business Initiative, the Division of Capital Asset Management and Maintenance (DCAMM) conveyed 44 acres of state land to the Worcester Business Development Corporation (WBDC). The land transfers took place in three phases, between December 2017 and October 2018. This acreage, which remained after construction of the new Worcester Recovery Center in 2012, will be repurposed as a center for bio-manufacturing and will facilitate the commercialization of bio-medical research taking place in Cambridge and Boston. The conveyance was authorized by Chapter 367 of the Acts of 2016.
WBDC envisions the development, over time, of 350,000+ square feet of bio-manufacturing space on seven sites, with the potential to create 500+ jobs.
The new bio-manufacturing campus is adjacent to the Worcester Biotech Park developed by WBDC in the 1980’s, next to an existing AbbVie research facility and blocks from the UMass Medical School. Worcester and Central Massachusetts are poised for growth in this sector due to the lower cost of housing, access to a talented workforce, proximity to the area’s research and development activity and the city’s eight colleges and universities.
Project Partners included the Governor’s and Lt. Governor’s offices, Massachusetts Biomedical Initiatives, Massachusetts Life Science Center, City of Worcester, Worcester Regional Chamber of Commerce, UMass Medical School, Worcester Business Development Corporation, Mass Development and DCAMM.